2023-2024 Regular Session • Wisconsin Legislature

AB950: Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.

Legislative Summary

An Act to create 895.532 and 961.571 (1) (b) 4. of the statutes; Relating to: excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.

Bill History

1/12/2024

Introduced

State Assembly

1/12/2024

Read first time and referred to Committee on Criminal Justice and Public Safety

State Assembly

2/1/2024

Public hearing held

State Assembly

2/1/2024

Representative Steffen added as a coauthor

State Assembly

2/1/2024

Senator Carpenter added as a cosponsor

State Assembly

2/2/2024

Representative Madison added as a coauthor

State Assembly

2/6/2024

Representative Emerson added as a coauthor

State Assembly

2/8/2024

Executive action taken

State Assembly

2/12/2024

Report passage recommended by Committee on Criminal Justice and Public Safety, Ayes 15, Noes 0

State Assembly

2/12/2024

Referred to committee on Rules

State Assembly

2/15/2024

Placed on calendar 2-20-2024 by Committee on Rules

State Assembly

2/20/2024

Representative Joers added as a coauthor

State Assembly

2/20/2024

Laid on the table

State Assembly

4/15/2024

Failed to pass pursuant to Senate Joint Resolution 1

State Assembly

Status Information

Current Status

Failed(4/15/2024)

Chamber

State Assembly

AB950: Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.

Legislative Summary

Bill History

Status Information

Sponsors

Primary Sponsor

Co-Sponsors (25)

Documents

External Links